会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • ADENOSINE INCORPORATION INHIBITOR
    • 腺苷合成抑制剂
    • WO1994019342A1
    • 1994-09-01
    • PCT/JP1994000229
    • 1994-02-16
    • KYOWA HAKKO KOGYO CO., LTD.FUJIWARA, ShigekiMACHII, DaisukeTAKAI, HarukiNONAKA, HiromiKASE, HiroshiYAO, KozoKAWAKAGE, MichiyoKUSAKA, HideakiKARASAWA, Akira
    • KYOWA HAKKO KOGYO CO., LTD.
    • C07D401/14
    • C07D401/14C07D491/04
    • An adenosine incorporation inhibitor and a drug for protecting cardiac muscles or preventing or treating inflammatory edema, each containing as the active ingredient a 1,2,3,4-tetrahydro-2,4-dioxoquinazoline derivative represented by general formula (I) or a pharmacologically acceptable salt thereof, wherein R represents hydrogen, (un)substituted lower alkyl, alkenyl or (un)substituted aralkyl; R , R , R and R represent each independently hydrogen, halogen, amino, mono- or di(lower alkyl) amino, lower alkanoyl amino, nitro, cyano, (un)substituted lower alkyl, hydroxy, lower alkoxy, lower alkylthio, carboxy, lower alkoxycarbonyl, lower alkanoyl, aralkyloxy or lower alkanoyloxy; R , R , R and R represent each independently hydrogen, hydroxy, (un)substituted lower alkoxy or aralkyloxy, or alternatively the two adjacent groups among them may be combined together to represent methylenedioxy; R represents hydrogen or lower alkyl; and Y and Z represent each independently N or C-R'', wherein R'' represents hydrogen, (un)substituted lower alkyl or halogen.
    • 一种腺苷并入抑制剂和用于保护心肌或预防或治疗炎症性水肿的药物,每种含有作为活性成分的通式(I)表示的1,2,3,4-四氢-2,4-二氧代喹唑啉衍生物或 其中R 1表示氢,(取代的)取代的低级烷基,烯基或(未)取代的芳烷基; R 2,R 3,R 4和R 5各自独立地表示氢,卤素,氨基,一或二(低级烷基)氨基,低级烷酰氨基,硝基,氰基,(取代) 低级烷基,羟基,低级烷氧基,低级烷硫基,羧基,低级烷氧基羰基,低级烷酰基,芳烷氧基或低级烷酰氧基; R 6,R 7,R 8和R 9各自独立地表示氢,羟基,(未)取代的低级烷氧基或芳烷氧基,或者它们中的两个相邻基团可以组合在一起代表亚甲二氧基 ; R 10代表氢或低级烷基; 并且Y和Z各自独立地表示N或C-R“,其中R”表示氢,(un)取代的低级烷基或卤素。
    • 4. 发明申请
    • INDOLE DERIVATIVE
    • WO1995019343A1
    • 1995-07-20
    • PCT/JP1995000019
    • 1995-01-11
    • KYOWA HAKKO KOGYO CO., LTD.MACHII, DaisukeTAKAI, HarukiKOSAKA, NobuoSEO, HisakatsuSUGIYAMA, TomomiNAKAMURA, JojiISHIDA, HiroyukiGOMI, KatsushigeSATO, SoichiroUCHII, Masako
    • KYOWA HAKKO KOGYO CO., LTD.
    • C07D209/42
    • C07D209/42
    • An indole derivative represented by general formula (I) or a pharmacologically acceptable salt thereof, wherein R and R may be the same or different and each represents hydrogen, lower alkyl, -(CH2)n-OR (R representing hydrogen or lower alkyl, and n representing an integer of 1 to 6), or -(CH2)m-NR R (wherein R and R may be the same or different and each represents hydrogen or lower alkyl, or alternatively R and R are combined to represent, together with the nitrogen atom to which they are bonded, an (un)substituted heteroalicyclic group, and m represents an integer of 2 to 6); R represents hydrogen, lower alkyl or -(CH2)p-NR R (wherein R and R may be the same or different and each represents hydrogen or lower alkyl, or alternatively R and R are combined to represent, together with the nitrogen atom to which they are bonded, an (un)substituted heteroalicyclic group, and p represents an integer of 2 to 6); and R and R may be the same or different and each represents hydrogen, lower alkyl, cycloalkyl, (un)substituted aryl or (un)substituted heterocycle, or alternatively R and R are combined to represent, together with the nitrogen atom to which they are bonded, an (un)substituted heteroalicyclic group.
    • 由通式(I)表示的吲哚衍生物或其药理学上可接受的盐,其中R 1和R 2可以相同或不同,各自表示氢,低级烷基, - (CH 2)n -OR 6 (R 6表示氢或低级烷基,n表示1〜6的整数)或 - (CH 2)m -NR 7 R 8(其中R 7和R 8可以 相同或不同,各自表示氢或低级烷基,或者R 7和R 8与它们所键合的氮原子一起代表与(un)取代的杂脂环基,m 表示2〜6的整数); R 3表示氢,低级烷基或 - (CH 2)p -NR NR 9 R 10(其中R 9和R 10可以相同或不同,各自表示氢或低级烷基,或 或者R 9和R 10与它们所键合的氮原子一起代表(取代的)杂脂环基,p表示2〜6的整数)。 R 4和R 5可以相同或不同,各自表示氢,低级烷基,环烷基,(未)取代的芳基或(未)取代的杂环,或者R 4和R 5分别为 与它们所键合的氮原子一起表示((un)取代的杂脂环基。